# TADLIQ

NDC: 46287-045
Generic name: Tadalafil
Labeler / Manufacturer: CMP Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20220830

FDA application: NDA214522

## Active ingredients

- TADALAFIL: 20 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46287-045"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46287-045
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7a909b25-3772-403e-a5fe-e4a040293fb7